Laser treatment for glaucoma can sound intimidating, but most patients finish in under a minute. Selective laser trabeculoplasty, or SLT, happens at a slit lamp in a clinic or surgery center. It requires no incisions and sends most patients home within the hour.
The sections below explain how the laser targets the eye’s drainage tissue. You’ll also learn what a major clinical trial found when SLT went head to head with daily eye drops, and what to expect at your own appointment.
Key Takeaways
- SLT uses short laser pulses to target pigmented cells in the eye’s drainage tissue, improving fluid outflow without cutting or burning.
- The active laser time is about 60 seconds, with the full visit lasting under an hour.
- Recovery is minimal, and most patients resume normal activities within a day or two.
- The LiGHT Trial found SLT works as well as daily eye drops for reaching target eye pressure.
- SLT can often be repeated years later if eye pressure rises again.
How Selective Laser Trabeculoplasty Targets the Eye’s Drainage Tissue
SLT works on a specific part of the eye called the trabecular meshwork. This tissue sits where the iris meets the cornea and controls how fluid drains out of the eye. When drainage slows down, fluid builds up, and pressure inside the eye rises. That rising pressure puts strain on the optic nerve, the structure that carries visual signals to the brain.
The trabecular meshwork contains pigmented cells that absorb certain wavelengths of light. SLT relies on that selectivity. Short pulses of laser energy target only those pigmented cells, while the surrounding tissue stays untouched. This precision is part of what makes the treatment so gentle on the eye.
Rather than burning or cutting, the laser triggers chemical and biological changes inside the targeted cells. These changes appear to prompt the eye’s own repair process. Over several weeks, that process gradually improves fluid outflow and lowers eye pressure. Many patients notice steady improvement rather than an instant change.
This gentle approach is what sets SLT apart from earlier laser methods used to treat glaucoma. Research published in PubMed Central explains that SLT avoids thermal damage to adjacent non-pigmented structures.
How does SLT differ from argon laser trabeculoplasty?
Argon laser trabeculoplasty, the older method, used a continuous beam that burned the trabecular meshwork directly. That thermal damage often caused scarring, so providers usually could not repeat the procedure safely.
SLT’s short pulses spare the surrounding tissue instead of burning it. The meshwork stays intact, so retreatment remains possible if pressure rises again later. The laser does not permanently alter the drainage channels. It only nudges them toward better function over time.
Doctors most often use SLT for open-angle glaucoma, where the drainage angle looks normal, but the meshwork filters poorly. It also treats ocular hypertension, when pressure runs high, but the optic nerve shows no damage yet. Both conditions involve a meshwork that isn’t filtering efficiently, which makes them well suited to a treatment built around restoring normal function.
What the Laser Treatment Actually Involves, Step by Step
Knowing what to expect can ease any nerves before the appointment. Here is what typically happens from preparation through follow-up care.
Before Your SLT Procedure
Preoperative steps take only a few minutes. A topical anesthetic drop numbs the eye surface first, so you won’t feel the laser shots during the procedure. Your doctor applies a small amount of contact lens gel to the eye. Your doctor then sets a specialized lens in place to guide the laser precisely onto the trabecular meshwork.
Most people are surprised by how straightforward the setup feels. There are no needles, no general anesthesia, and no operating room lights to worry about. The entire visit, including check-in and pressure checks, usually wraps up within an hour.
During the SLT Procedure
The procedure itself follows a simple, predictable sequence:
- You sit at a slit lamp while the ophthalmologist views the drainage tissue clearly.
- The laser fires a series of short pulses, usually about 100 shots spaced around the meshwork.
- Active laser time totals about 2.4 seconds, though the full visit runs a bit longer.
- Most patients notice very little, and any flashes of light or mild pressure pass quickly.
For most people, the sensation is mild rather than painful. According to the American Academy of Ophthalmology, you may feel a stinging sensation as the laser fires, but it passes almost immediately.
After Your SLT Procedure
SLT is outpatient surgery that takes place in a clinic setting rather than an operating room. The procedure needs no stitches and no recovery room afterward. Most patients leave within an hour of finishing the treatment.
An ophthalmologist performs the entire procedure from start to finish.
The hours right after treatment matter too.
Common effects in the hours and days that follow include:
- Mild eye redness that fades within a day or two
- Occasional light sensitivity that clears up quickly
- Slightly blurry vision right after the laser is used
- A need to avoid rubbing the treated eye for a day
Most patients describe the whole experience as far less involved than they expected going in. Once eye pressure checks confirm everything looks stable, you are free to resume most normal activities the same day.
Your doctor will likely recommend anti-inflammatory drops or artificial tears for a few days afterward. Follow-up visits typically happen at one month, when your doctor checks eye pressure and vision. The full pressure-lowering effect of SLT builds gradually over four to eight weeks.
SLT vs. Glaucoma Drops: What the LiGHT Trial Revealed
For years, eye drops were the standard first step for treating elevated eye pressure. Doctors mostly reserved SLT for cases when drops weren’t enough on their own. The LiGHT Trial set out to test whether that order actually made clinical sense.
Before this research, a study in The Lancet found that selective laser trabeculoplasty was rarely used as first-line treatment despite years of safety data. This mattered because millions of people manage glaucoma with drops long term. Any treatment that reduces daily burden while protecting vision is worth serious consideration.
What the LiGHT Trial Found
The LiGHT trial, short for Laser in Glaucoma and Ocular Hypertension, enrolled patients with open-angle glaucoma or ocular hypertension. Researchers included only patients with a new diagnosis and no prior treatment. They randomly assigned each person to start with either SLT or topical medication.
Patients in the SLT group were just as likely to reach their target eye pressure as those using drops. A notable share of them needed no further treatment at all during the study period. That result surprised many providers who had long viewed SLT as a backup option. The findings also held up over extended follow-up, not just in the first few months. Longer-term data continue to support SLT as a reasonable starting point for many patients.
The trial also drew attention to medication adherence. Daily drops require a consistent routine that patients often apply twice a day for years at a time. Missing doses, dealing with side effects, or struggling with the mechanics of applying drops can affect pressure control. Consistency matters more than people often expect.
SLT works differently because it acts continuously after a single session, rather than relying on daily upkeep. Many patients see lasting results for years afterward. Data indexed in PubMed Central show many patients remaining drop-free for at least 6 years in published follow-up records.
When SLT Isn’t the Right Fit
SLT isn’t the right fit for every type of glaucoma, though. A few examples include:
- Angle-closure glaucoma, which involves a narrowed drainage angle rather than a meshwork filtering problem
- Pseudoexfoliation glaucoma, which may respond to SLT but often needs closer monitoring afterward
- Severe optic nerve damage, which may call for surgery instead of laser treatment first
Your ophthalmologist will review your specific eye anatomy and glaucoma type before recommending SLT or another approach. This evaluation helps avoid wasted time on a treatment unlikely to work well for your eyes.
Other laser options exist for patients who don’t qualify for SLT or need additional pressure reduction. Micropulse laser trabeculoplasty uses a pulsed delivery pattern and is available at some practices. The cyclodiode laser targets the ciliary body instead of the drainage tissue. Doctors typically reserve it for more advanced cases. Which option fits best depends on your full clinical picture.
Your care plan should reflect your specific eye pressure, glaucoma type, and daily routine. Talking with your provider helps you weigh SLT against other options and understand what results to expect.
Across every approach, the clinical goal stays the same. Providers aim to slow glaucoma progression and protect remaining vision before any damage becomes permanent.
Here’s Why Laser Treatment for Glaucoma is Becoming a First-Line Solution
Laser treatment for glaucoma does not have to feel overwhelming once you understand what SLT involves. Many patients are relieved to learn how quick and low-risk it really is. The procedure targets the eye’s natural drainage system in about a minute, with minimal downtime and no incisions. The LiGHT Trial confirmed it holds up well against daily eye drops. That gives you a real alternative worth discussing with a specialist. Most people find the appointment far shorter and easier than they imagined.
If your eye pressure is elevated or you have glaucoma, now is a good time to explore your options. You can schedule a glaucoma consultation with our team to find out if SLT fits your situation today!
FAQs
How long do the results of SLT laser surgery last?
SLT results typically last 1-2 years (sometimes up to 6 years), though this varies by patient. Eye pressure is checked at follow-up visits, and if it rises again, SLT can usually be repeated. Because the procedure doesn’t scar the meshwork, retreatment often stays an option.
Who is a good candidate for SLT eye surgery?
Patients with open-angle glaucoma or ocular hypertension are the most common candidates. A thorough eye exam, including a look at the drainage angle and a baseline pressure reading, helps determine whether SLT is a good fit for your eyes.
Can SLT be repeated if eye pressure rises again?
Yes, in most cases. SLT targets only pigmented cells without causing collateral damage to surrounding tissue, so the meshwork stays structurally intact. That’s a meaningful difference from older laser treatments, which caused enough scarring to rule out a second procedure.
Does SLT affect other eye conditions or planned cataract surgery?
SLT doesn’t interfere with cataract surgery. The two procedures work on different structures entirely. If both are part of your care plan, your ophthalmologist will coordinate the timing. The laser technology used for each operates independently, so one doesn’t compromise the other.
What should patients expect at their follow-up after SLT?
Your doctor will measure intraocular pressure to see how the treatment is working. The full effect takes four to eight weeks to develop, so an early reading may look incomplete. Your care team will decide whether your drops should continue, change, or stop.
